Conjunctivitis, Allergic - Therapy
Research News and Information

Sunday, November 22, 2009

Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study.

18 Apr 2009 BACKGROUND: Epidemiological evidence suggests that hookworm infection protects against asthma. However, for ethical and safety reasons, before testing this hypothesis in a clinical trial in asthma it is necessary to establish whether experimental ... Read more...

[House dust mite allergy: myths and realities]

13 Apr 2009 Since 1967, house dust mites have been shown to be the main allergens to be blamed in household dust allergy. In our countries, Dermatophagoides pteronyssinus and Dermatophagoides farinae are predominant. We find them by millions in our bedding. ... Read more...

Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy.

30 Mar 2009 The clinical efficacy of immunotherapy, either by high dose sublingual-swallow therapy (SLIT) or subcutaneous immunotherapy (SCIT), has been demonstrated in patients with pollinosis but few studies have been carried out analysing differences in ... Read more...

Latest indexed articles for 'Conjunctivitis, Allergic - Therapy'

These are the very latest articles for this heading:

• Sublingual immunotherapy in children: more optimism today. 21 Sep 2009
• [Recognizing and understanding illnesses: "inflamed eyes" as the leading symptom] 30 May 2009
• Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study. 18 Apr 2009
• [House dust mite allergy: myths and realities] 13 Apr 2009
• The red eye: evaluation and management. 6 Apr 2009
• Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy. 30 Mar 2009
• High-dose sublingual immunotherapy in children at 8-year follow-up. 27 Feb 2009
• Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. 27 Feb 2009
• Allergic rhinoconjunctivitis: complementary treatments for the 21st century. 27 Feb 2009
• CD-sens: a biological measure of immunological changes stimulated by ASIT. 11 Feb 2009
• Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX) in a randomized, open-label, controlled study: an a priori subgroup analysis. 30 Jan 2009
• [Allergic rhinoconjunctivitis and immunotherapy: an update] 12 Jan 2009
• The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy. 30 Dec 2008
• Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. 30 Dec 2008
• Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis. 22 Dec 2008
• Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. 21 Dec 2008
• Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. 3 Dec 2008
• Sublingual immunotherapy: what have we learnt from the 'big trials'? 29 Nov 2008
• Usefulness of sublingual immunotherapy in children. 29 Nov 2008
• Quality of life (QoL): impact of specific immunotherapy (SIT) on social and physical ability. 29 Nov 2008

See a longer list of these articles.

Technical information about 'Conjunctivitis, Allergic'

Definition: Conjunctivitis due to hypersensitivity to various allergens.

Descriptor UI: D003233

Alternative terms: Conjunctivitis, Allergic; Conjunctivitis, Atopic; Atopic Conjunctivitides; Atopic Conjunctivitis; Conjunctivitides, Atopic; Allergic Conjunctivitis; Allergic Conjunctivitides; Conjunctivitides, Allergic; Conjunctivitis, Vernal; Conjunctivitides, Vernal; Vernal Conjunctivitides; Vernal Conjunctivitis; Keratoconjunctivitis, Vernal; Keratoconjunctivitides, Vernal; Vernal Keratoconjunctivitides; Vernal Keratoconjunctivitis; Conjunctivitis, Giant Papillary; Conjunctivitides, Giant Papillary; Giant Papillary Conjunctivitides; Giant Papillary Conjunctivitis; Papillary Conjunctivitides, Giant; Papillary Conjunctivitis, Giant;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C11.187.183.200; C20.543.480.200;

History Note: 86

Technical Notes: coord IM with etiol of the allergy (IM) if specified